KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $509,115 | -27.2% | 36,627 | +20.4% | 0.00% | – |
| Q2 2023 | $699,586 | -87.5% | 30,430 | -83.9% | 0.00% | -100.0% |
| Q1 2023 | $5,614,470 | +1567.1% | 189,486 | +1304.3% | 0.00% | – |
| Q4 2022 | $336,785 | +14.6% | 13,493 | -0.0% | 0.00% | – |
| Q3 2022 | $294,000 | +10.1% | 13,496 | -0.5% | 0.00% | – |
| Q2 2022 | $267,000 | -58.9% | 13,563 | -11.8% | 0.00% | – |
| Q1 2022 | $650,000 | -32.8% | 15,371 | +1.0% | 0.00% | – |
| Q4 2021 | $967,000 | +7.0% | 15,225 | -1.1% | 0.00% | – |
| Q3 2021 | $904,000 | +100.9% | 15,396 | +66.2% | 0.00% | – |
| Q2 2021 | $450,000 | – | 9,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |